Interleukin-6 promotes destabilized angiogenesis by modulating angiopoietin expression in rheumatoid arthritis

Rheumatology (United Kingdom)

Volumn 51, Issue 9, 2012, Pages 1571-1579

  Kayakabe, Ken ^a   Kuroiwa, Takashi ^b   Sakurai, Noriyuki ^a   Ikeuchi, Hidekazu ^a   Kadiombo, Anastasie Tshilela ^a   Sakairi, Toru ^a   Matsumoto, Takayuki ^a   Maeshima, Akito ^a   Hiromura, Keiju ^a   Nojima, Yoshihisa ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Angiogenesis; Angiopoietin; IL 6; Rheumatoid arthritis; VE cadherin; VEGF

Indexed keywords

ANGIOPOIETIN; ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANTIBODY; CD31 ANTIBODY; CD31 ANTIGEN; CELL SURFACE PROTEIN; INTERLEUKIN 6; RECOMBINANT ANGIOPOIETIN 1; RECOMBINANT INTERLEUKIN 6; RECOMBINANT PROTEIN; RECOMBINANT VASCULOTROPIN; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CELL STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERNALIZATION; MOLECULAR PATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SYNOVIUM; UMBILICAL VEIN ENDOTHELIAL CELL;

ANGIOPOIETIN-1; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; CELL PROLIFERATION; COCULTURE TECHNIQUES; FIBROBLASTS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTERLEUKIN-6; NEOVASCULARIZATION, PATHOLOGIC; RECOMBINANT PROTEINS; SYNOVIAL MEMBRANE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84865325999     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kes093     Document Type: Article

References (27)

1. Izquierdo E, Cañete JD, Celis R et al. Immature blood vessels in rheumatoid synovium are selectively depleted in response to anti-TNF therapy. PLoS One 2009;4:e8131.
2. Kennedy A, Ng CT, Biniecka M, Saber T et al. Angiogenesis and blood vessel stability in inflammatory arthritis. Arthritis Rheum 2010;62:711-21.
3. Szekanecz Z, Koch EA. Angiogenesis and its targeting in rheumatoid arthritis. Vascul Pharmacol 2009;51:1-7.
4. Nakahara H, Song J, Sugimoto M et al. Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis. Arthritis Rheum 2003;48:1521-9.
5. Hashizume M, Hayakawa N, Suzuki M, Mihara M. IL-6/ sIL-6R trans-signalling, but not TNF-alpha induced angiogenesis in a HUVEC and synovial cell co-culture system. Rheumatol Int 2009;29:1449-54.
6. Cho ML, Cho CS, Min SY et al. Cyclosporine inhibition of vascular endothelial growth factor production in rheumatoid synovial fibroblasts. Arthritis Rheum 2002;46:1202-9.
7. Mor A, Abramson SB, Pillinger MH. The fibroblast-like synovial cell in rheumatoid arthritis: a key player in inflammation and joint destruction. Clin Immunol 2005;115: 118-28.
8. Eklund L, Olsen BR. Tie receptors and their angiopoietin ligands are context-dependent regulators of vascular remodeling. Exp Cell Res 2006;312:630-41.
9. Fukuhara S, Sako K, Noda K et al. Tie2 is tied at the cell-cell contacts and to extracellular matrix by angiopoietin-1. Exp Mol Med 2009;41:133-9.
10. Fiedler U, Scharpfenecker M, Koidl S et al. The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies. Blood 2004;103:4150-6.
11. Hansen TM, Singh H, Tahir TA, Brindle NP. Effects of angiopoietins-1 and -2 on the receptor tyrosine kinase Tie2 are differentially regulated at the endothelial cell surface. Cell Signal 2010;22:527-32.
12. Thurston G, Suri C, Smith K et al. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 1999;286:2511-4.
13. Thurston G, Rudge JS, Ioffe E et al. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med 2000;6:460-3.
14. Gavard J, Patel V, Gutkind JS. Angiopoietin-1 prevents VEGF-induced endothelial permeability by sequestering Src through mDia. Dev Cell 2008;14:25-36.
15. Gavard J, Gutkind JS. VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin. Nat Cell Biol 2006;8:1223-34.
16. Takahara K, Iioka T, Furukawa K et al. Autocrine-paracrine role of the angiopoietin-1 and -2-Tie2 system in cell proliferation and chemotaxis of cultured fibroblastic synoviocytes in rheumatoid arthritis. Hum Pathol 2004;35:150-8.
17. DeBusk LM, Chen Y, Nishishita T et al. Tie2 receptor tyrosine kinase, a major mediator of tumor necrosis factor alpha-induced angiogenesis in rheumatoid arthritis. Arthritis Rheum 2003;48:2461-71.
18. Gravallese EM, Pettit a R, Lee R et al. Angiopoietin-1 is expressed in the synovium of patients with rheumatoid arthritis and is induced by tumour necrosis factor alpha. Ann Rheum Dis 2003;62:100-7.
19. Ikeuchi H, Kuroiwa T, Hiramatsu N et al. Expression of interleukin-22 in rheumatoid arthritis: potential role as a proinflammatory cytokine. Arthritis Rheum 2005;52: 1037-46.
20. Winderlich M, Cagna G, Nottebaum AF. Cell adhesion dynamics at endothelial junctions: VE-cadherin as a major player. Trends Cell Biol 2008;19:8-15.
21. Suri C, Jones PF, Patan S et al. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 1996;87:1171-80.
22. Westra J, de Groot L, Plaxton SL et al. Angiopoietin-2 is highly correlated with inflammation and disease activity in recent-onset rheumatoid arthritis and could be predictive for cardiovascular disease. Rheumatology 2011;50: 665-73.
23. Kurosaka D, Hirai K, Nishioka M et al. Clinical significance of serum levels of vascular endothelial growth factor, angiopoietin-1, and angiopoietin-2 in patients with rheumatoid arthritis. J Rheumatol 2010;37:1121-8.
24. Chen Y, Donnelly E, Kobayashi H, Debusk LM, Lin PC. Gene therapy targeting the Tie2 function ameliorates collagen-induced arthritis and protects against bone destruction. Arthritis Rheum 2005;52:1585-94.
25. Hashiramoto A, Sakai C, Yoshida K et al. Angiopoietin 1 directly induces destruction of the rheumatoid joint by cooperative, but independent, signaling via ERK/MAPK and phosphatidylinositol 3-kinase/Akt. Arthritis Rheum 2007;56:2170-9.
26. Vestweber D. Adhesion and signaling molecules controlling the transmigration of leukocytes through endothelium. Immunol Rev 2007;218:178-96.
27. Bettelli E, Carrier Y, Gao W et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006;441:235-8.